These additional ICs include PD-1, TIM-3, TIGIT, LAG-3 and can be up-regulated and/or de-novo expressed in pathological conditions such as infections or under the influence of the tumor microenvironment (TME) (4, 8), weakening NK responses. The gene discussed is HAVCR2; the disease is neoplasm.